Share Capital - Additional Information (Detail)
|
|
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
12 Months Ended |
|
|
|
|
|
|
Dec. 18, 2018
$ / shares
|
Dec. 18, 2018
$ / shares
|
Aug. 10, 2018
USD ($)
$ / shares
shares
|
Jun. 19, 2018
shares
|
May 10, 2018
USD ($)
$ / shares
|
May 10, 2018
USD ($)
shares
|
Apr. 10, 2018
USD ($)
$ / shares
|
Apr. 10, 2018
USD ($)
shares
|
Dec. 05, 2017
USD ($)
$ / shares
|
Dec. 05, 2017
USD ($)
shares
|
Aug. 24, 2017
$ / shares
|
Aug. 24, 2017
USD ($)
|
Jul. 21, 2017
USD ($)
$ / shares
|
Jul. 21, 2017
USD ($)
shares
|
Jun. 29, 2017
USD ($)
$ / shares
|
Jun. 29, 2017
USD ($)
shares
|
Mar. 16, 2017
USD ($)
$ / shares
|
Mar. 16, 2017
USD ($)
shares
|
Nov. 23, 2015
USD ($)
|
Dec. 31, 2017
USD ($)
|
Dec. 31, 2018
USD ($)
shares
|
Dec. 31, 2017
USD ($)
shares
|
Dec. 31, 2018
CAD ($)
shares
|
Dec. 31, 2018
$ / shares
|
Dec. 31, 2017
CAD ($)
shares
|
Dec. 31, 2017
$ / shares
|
Oct. 31, 2017
$ / shares
shares
|
Aug. 24, 2017
USD ($)
shares
|
Dec. 31, 2016
CAD ($)
|
Nov. 23, 2015
$ / shares
shares
|
Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Par value per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
|
$ 0
|
|
|
|
|
Shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21,675,849
|
|
12,686,723
|
|
|
|
|
|
Number of shares outstanding | shares |
|
|
|
419,888,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21,675,849
|
|
12,686,723
|
|
|
|
|
|
Number of shares outstanding, adjusted | shares |
|
|
|
13,996,275
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reverse stock split ratio |
|
|
|
0.0333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective date of reverse stock split |
|
|
|
Jun. 20, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash commission |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 785,128
|
$ 598,804
|
|
|
|
|
|
|
|
|
Amount allocated to common shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 17,392,158
|
|
|
|
|
|
|
|
|
Warrant exercised | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,500
|
|
1,755,141
|
|
|
|
|
|
Market value of common shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,887,411
|
|
|
Common stock market value per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain (loss) on extinguishment of warrant liability |
|
|
|
|
|
|
|
|
|
|
|
$ 709,782
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common shares available for issue under stock option plan | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,241,803
|
677,063
|
|
|
|
|
|
|
|
|
Percentage of common shares reserved for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
|
Weighted average exercise price of options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 17.32
|
|
$ 21.30
|
|
|
|
$ 33.00
|
|
Weighted average exercise price of options exercisable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 18.84
|
|
|
|
|
|
|
|
Exercise price share options issued | (per share) |
$ 2.09
|
$ 1.55
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion rate per dollar |
1.3461
|
1.3461
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Over Allotment Option 1 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercised | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,755,141
|
|
|
|
|
|
Proceeds from warrant exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 9,438,577
|
|
|
|
|
|
|
|
|
Amount reclassed from warrant liability to common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7,953,581
|
|
|
|
|
|
|
|
|
Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
446,197
|
|
|
|
Subscription price of common share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7.50
|
|
|
|
Gross proceeds from issuance of common shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,677,326
|
|
|
|
|
|
|
|
|
|
|
Bloom Burton Securities Inc [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of offering units | shares |
|
|
7,679,574
|
|
|
|
|
1,126,664
|
|
1,533,333
|
|
|
|
370,567
|
|
1,612,955
|
|
715,573
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price per share | (per share) |
|
|
$ 2.50
|
|
$ 9.00
|
|
$ 9.00
|
|
$ 15.00
|
|
|
|
$ 4.50
|
|
$ 4.50
|
|
$ 10.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross proceeds from offerings |
|
|
$ 19,198,935
|
|
|
|
|
$ 8,035,941
|
|
$ 18,137,800
|
|
|
|
$ 1,328,871
|
|
$ 5,576,357
|
|
$ 5,642,537
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash commission |
|
|
1,343,925
|
|
|
$ 76,988
|
|
562,516
|
|
1,246,185
|
|
|
|
93,021
|
|
382,689
|
|
394,316
|
|
|
|
|
|
|
|
|
|
|
|
|
Net proceeds from offering |
|
|
$ 17,464,711
|
|
|
|
|
7,211,320
|
|
16,555,875
|
|
|
|
1,200,788
|
|
4,838,002
|
|
5,039,817
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share | (per share) |
|
|
$ 3.20
|
|
$ 10.50
|
|
$ 10.50
|
|
$ 18.00
|
|
|
|
$ 6.00
|
|
$ 6.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrants |
|
|
$ 6,297,251
|
|
$ 658,387
|
658,387
|
$ 4,553,700
|
4,553,700
|
$ 5,223,686
|
5,223,686
|
|
|
$ 575,844
|
575,844
|
$ 2,788,274
|
2,788,274
|
$ 1,297,810
|
1,297,810
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount allocated to common shares |
|
|
$ 12,901,684
|
|
|
$ 531,469
|
|
$ 3,482,241
|
|
$ 12,914,114
|
|
|
|
$ 753,027
|
|
$ 2,788,083
|
|
$ 4,344,727
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expiration period |
|
|
Aug. 10, 2023
|
|
|
Apr. 10, 2023
|
|
Apr. 10, 2023
|
|
Dec. 05, 2022
|
|
|
|
Jun. 29, 2022
|
|
Jun. 29, 2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of offering additional units | shares |
|
|
|
|
|
168,888
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross proceeds from additional offerings |
|
|
|
|
|
$ 1,189,856
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net proceeds from additional offering |
|
|
|
|
|
$ 1,100,238
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bloom Burton Securities Inc [member] | Exercise Prices Range One [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 12.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expiration period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mar. 16, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
Bloom Burton Securities Inc [member] | Exercise Prices Range Two [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expiration period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mar. 16, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
Bloom Burton Securities Inc [member] | Over Allotment Option 1 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expiration period |
|
|
Aug. 10, 2020
|
|
|
Apr. 10, 2020
|
|
Apr. 10, 2020
|
|
Dec. 05, 2019
|
|
|
|
Jun. 29, 2019
|
|
Jun. 29, 2019
|
|
Mar. 16, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
Broker Warrants to purchase of common stock | shares |
|
|
537,570
|
|
|
10,928
|
|
78,867
|
|
105,350
|
|
|
|
25,940
|
|
109,533
|
|
50,005
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock price per share | (per share) |
|
|
$ 2.50
|
|
$ 9.00
|
|
$ 9.00
|
|
$ 15.00
|
|
|
|
$ 4.50
|
|
$ 4.50
|
|
$ 10.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Longtai Medical Inc [member] | Sales marketing and distribution agreement [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deposit towards distributorship agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,000,000
|
|
|
|
|
|
|
|
|
|
|
|
Longtai Medical Inc [member] | Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
143,009
|
Subscription price of common share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 36.90
|
Gross proceeds from issuance of common shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,000,000
|
|
|
|
|
|
|
|
|
|
|
|
Longtai Medical Inc [member] | Subscription Agreement [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disclosure of classes of share capital [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
563,067
|
|
|
Exercise price per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
6.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity conversion deposit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.0
|
|
|
Share price per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 4.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Description of share conversion |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Each Unit consists of one Common Share and one Common Share purchase warrant, with each warrant exercisable for one Common Share at an exercise price of CDN $6.00 per warrant and will expire August 24, 2022. The warrants were valued at $822,372 based on the value determined by the Black-Scholes model.
|
|
|
|
|
|
|
|
|
|